Glycomine

Glycomine is a biotech company in San Carlos, United States. It has raised $195.0M across 3 rounds, most recently a $115.0M Series C in April 2025.

Replacement Therapies for Rare Diseases| PMM2-CDG

Employees
1–10
Business Model
B2B
Total Funding
$195.0M
Last Round
$115.0M Series CApr 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Glycomine develops replacement therapies for serious rare genetic diseases, many of which have no disease-modifying treatment options. Its approach addresses protein dysfunction caused by genetic mutations by replacing a protein or delivering a substrate or enzyme that bypasses the deficient protein. The company then uses its platform to deliver the therapy to clinically relevant cells and organ systems, building a pipeline intended to address a range of rare diseases and unmet patient needs.

Summary

It lists 1–10 employees. It has raised $195.0M in total across 3 rounds, most recently a $115.0M Series C round in Apr 2025. Investors include Remiges Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CApr 2025
$115.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Glycomine on Indexed.vc
<a href="https://indexed.vc/companies/glycomine"><img src="https://indexed.vc/api/badge/company/glycomine" alt="Glycomine on Indexed.vc" width="260" height="76" /></a>